BRGX (BioRegenx) LT-Debt-to-Total-Asset : 0.02 (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is BioRegenx LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. BioRegenx's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.02.

BioRegenx's long-term debt to total assets ratio increased from Sep. 2023 (0.00) to Sep. 2024 (0.02). It may suggest that BioRegenx is progressively becoming more dependent on debt to grow their business.

BioRegenx LT-Debt-to-Total-Asset Historical Data

The historical data trend for BioRegenx's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRegenx LT-Debt-to-Total-Asset Chart

BioRegenx Annual Data

Trend

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.41

1.55

3.32

BioRegenx Quarterly Data
	Dec04	Mar05	Jun05	Sep05	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	0.01	0.01	0.02

BioRegenx LT-Debt-to-Total-Asset Calculation

BioRegenx's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0	/	0.032
	=	0.00

BioRegenx's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	0.282	/	17.361
	=	0.02

BioRegenx (OTCPK:BRGX) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

BioRegenx LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of BioRegenx's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

BioRegenx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

7407 Ziegler Road, Chattanooga, TN, USA, 37421

Website

https://www.bioregenx.com

BioRegenx Inc is redefining health intelligence with new patented technologies and artificial intelligence. Its specialize in developing intellectual property (IP) and are engaged in regenerative biotherapeutics, anti-aging, artificial intelligence (AI) for healthcare and bioinformatics for public and private transportation. The primary focus involves acquiring or developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing extensive datasets.